financetom
AMPH
financetom
/
Healthcare
/
AMPH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Amphastar Pharmaceuticals, Inc.AMPH
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API).

It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures.

In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock.

Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Latest News >
Update: Marimaca Copper Up 24% as It Provides Drill Results From the Pampa Medina Deposit in Chile
Update: Marimaca Copper Up 24% as It Provides Drill Results From the Pampa Medina Deposit in Chile
Jul 3, 2025
11:44 AM EDT, 07/03/2025 (MT Newswires) -- (Adds comment and updates shares.) Marimaca Copper ( MARIF ) shares rose 24% to a record after the company on Thursday reported significant copper sulfide and oxide intersections that extended the Pampa Medina deposit located 28 kilometers east of its Marimaca oxide deposit in Chile. Highlights include 6 meters of 12.0% copper within...
Update: Ero Copper Starts Commercial Production at Tucuma Operation in Brazil
Update: Ero Copper Starts Commercial Production at Tucuma Operation in Brazil
Jul 3, 2025
11:36 AM EDT, 07/03/2025 (MT Newswires) -- (Adds comment and updates shares.) Ero Copper ( ERO ) said Thursday that its Tucuma mine in Brazil began commercial production on July 1. During June the mine and mill reached sustained throughput levels exceeding 75% of design capacity following the completion of commissioning of the third filter press as well as modifications...
Code of practice to help firms comply with AI rules may apply end 2025, EU says
Code of practice to help firms comply with AI rules may apply end 2025, EU says
Jul 3, 2025
BRUSSELS, July 3 (Reuters) - A code of practice designed to help thousands of companies comply with the European Union's landmark artificial intelligence rules may only apply at the end of 2025, the European Commission said on Thursday. Alphabet's Google, Meta Platforms ( META ), European companies such as Mistral and ASML as well as several EU governments have called...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved